Alzamend Neuro, Inc. (ALZN)


Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Alzamend Neuro, Inc. chart...

About the Company

We do not have any company description for Alzamend Neuro, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

6

Exchange

Nasdaq

$M

Total Revenue

6

Employees

$5M

Market Capitalization

-11.30

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ALZN News

Alzamend Neuro (ALZN) Price Target Decreased by 16.00% to 21.42

8d ago, source: Hosted on MSN

The average one-year price target for Alzamend Neuro (NasdaqCM:ALZN) has been revised to 21.42 / share. This is an decrease ...

Alzamend Neuro Inc.

29d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Alzamend Neuro Inc Ordinary Shares

22d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Buy Rating Justified by Alzamend Neuro’s Promising Alzheimer’s Treatments and Attractive Valuation

10d ago, source:

Ascendiant analyst Edward Woo maintained a Buy rating on Alzamend Neuro (ALZN – Research Report) yesterday and set a price target of ...

Alzamend Neuro shares target cut, retains buy rating

11d ago, source: Investing

On Monday, Ascendiant Capital adjusted its outlook on Alzamend Neuro Inc (NASDAQ:ALZN), a biopharmaceutical company. The firm reduced the 12-month price target to $21 from the previous $25 while ...

Alzamend Neuro director Milton Ault III buys $304 in shares

22d ago, source: Investing

Ault III, a director and significant shareholder of Alzamend Neuro, Inc. (NASDAQ:ALZN), has increased his stake in the company. The transaction was executed on April 1, 2024, and reported in a ...

Alzamend Neuro director Milton Ault III buys $304 in shares

22d ago, source: Investing

In a recent move that has caught the attention of investors, Milton C. Ault III, a director and significant shareholder of Alzamend Neuro, Inc. (NASDAQ:ALZN), has increased his stake in the company.

Alzamend Neuro, Inc. (ALZN)

27d ago, source: Yahoo Finance

*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

Alzamend Neuro Inc (ALZN)

7d ago, source: Investing

All relevant comments and Alzamend Neuro Inc share chat regarding the ALZN NASDAQ share news are listed here in the ALZN forum. View and contribute to the ALZN share chat. Discuss Alzamend Neuro Inc ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...